Recognition of linear B-cell epitope of Betanodavirus coat protein by RG-M18 neutralizing mAB inhibits giant grouper nervous necrosis virus (GGNNV) infection

Abstract

Betanodavirus is a causative agent of viral nervous necrosis syndrome in many important aquaculture marine fish larvae, resulting in high global mortality. The coat protein of Betanodavirus is the sole structural protein, and it can assemble the virion particle by itself. In this study, we used a high-titer neutralizing mAB, RG-M18, to identify the linear B-cell epitope on the viral coat protein. By mapping a series of recombinant proteins generated using the E. coli PET expression system, we demonstrated that the linear epitope recognized by RG-M18 is located at the C-terminus of the coat protein, between amino acid residues 195 and 338. To define the minimal epitope region, a set of overlapping peptides were synthesized and evaluated for RG-M18 binding. Such analysis identified the 195 VNVSVLCR 202 motif as the minimal epitope. Comparative analysis of Alanine scanning mutagenesis with dotblotting and ELISA revealed that Valine 197, Valine 199, and Cysteine 201 are critical for antibody binding. Substitution of Leucine 200 in the RGNNV, BFNNV, and TPNNV genotypes with Methionine 200 (thereby simulating the SJNNV genotype) did not affect binding affinity, implying that RG-M18 can recognize all genotypes of Betanodaviruses. In competition experiments, synthetic multiple antigen peptides of this epitope dramatically suppressed giant grouper nervous necrosis virus (GGNNV) propagation in grouper brain cells. The data provide new insights into the protective mechanism of this neutralizing mAB, with broader implications for Betanodavirus vaccinology and antiviral peptide drug development.